Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online November 15, 2020.
Article Versions
- You are currently viewing a Latest version of this article (November 15, 2020 - 04:00).
- latest version (December 15, 2020 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2020 The Journal of Rheumatology
Author Information
- Sofia Pazmino,
- Anikó Lovik,
- Annelies Boonen,
- Diederik De Cock,
- Veerle Stouten,
- Johan Joly,
- Delphine Bertrand,
- Kristien van der Elst,
- René Westhovens and
- Patrick Verschueren
- Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium.
Funding: The CareRA trial (EudraCT number: 2008-007225-39) was funded by a Flemish governmental grant (Agency for Innovation by Science and Technology [IWT]). Patrick Verschueren holds the Pfizer chair for early rheumatoid arthritis management at the KU Leuven.
Address correspondence to Sofia Pazmino, Division of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. E-mail: sofia.pazmino@kuleuven.be